Human Growth Hormone alternatives.
10 compounds compared to Human Growth Hormone, ranked by published evidence tier and regulatory status, not by what's marketed hardest.
Growth hormone alternatives searches are driven by two things: cost and the prescription. Recombinant somatropin is approved for a specific list of indications including pediatric and adult GH deficiency, Turner syndrome, and HIV-associated wasting, and in the US distribution for non-approved uses such as anti-aging, bodybuilding, or athletic enhancement is specifically restricted by law. That legal wall is the reason the entire secretagogue market exists. The honest framing: secretagogues prompt the pituitary to release your own GH rather than supplying the hormone, so they are not equivalent, almost none are approved for any indication, and GH itself is prohibited in and out of competition by WADA.
Human growth hormone (hGH, also called somatotropin) is a 191-amino-acid, single-chain polypeptide hormone secreted by somatotroph cells of the anterior pituitary gland.
- 01IGF-1 LR3F tierResearch / preclinical
Acts through the igf-1 pathway pathway, like Human Growth Hormone. Research / preclinical.
- 02MGFF tierResearch / preclinicalmechano growth factor · IGF-1Ec
Acts through the igf-1 pathway pathway, like Human Growth Hormone. Research / preclinical.
- 03PEG-MGFF tierResearch / preclinical
Acts through the igf-1 pathway pathway, like Human Growth Hormone. Research / preclinical.
- 04
- 05SermorelinC tierResearch / preclinical
Same category: growth hormone. Research / preclinical.
- 06
- 07GHRP-1D tierResearch / preclinicalgrowth hormone-releasing peptide-1
Same category: growth hormone. Research / preclinical.
- 08GHRP-2D tierResearch / preclinical
Same category: growth hormone. Research / preclinical.
- 09GHRP-6D tierResearch / preclinical
Same category: growth hormone. Research / preclinical.
- 10HexarelinD tierResearch / preclinical
Same category: growth hormone. Research / preclinical.
An “alternative” here means a compound that shares Human Growth Hormone's mechanism pathway or sits in the same category, not a marketing substitute. Each is ordered by PepCue's evidence tier (a weighted 0–100 score across human data, safety, replication and regulatory clarity), then by whether it's actually approved. This is a research reference, not medical or purchasing advice: an alternative sitting higher on evidence does not mean it's right, safe, or legal for any given use. Reviewed June 1, 2026.
PepCue keeps every compound, dose and lab in one private, provider-ready timeline, whichever one you land on.